Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE

4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE

4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE structure

4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE 

structure
  • CAS No:

    162408-66-4

  • Formula:

    C30H35N3O3

  • Chemical Name:

    4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE

  • Synonyms:

    4""-acetyl-N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)(1,1""-biphenyl)-4-carboxamide;GR 103691;GR-103691;GR103691;4"-Acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-[1,1"-biphenyl]-4-carboxamide;UNII-0Y0CM1A77L;0Y0CM1A77L;CHEMBL294747

Description

GR 103691 is a potent, selective dopamine D3 receptor antagonist with a Ki value of 0.4 nM. GR 103691 shows more than 100-fold selectivity for human dopamine human (h)D3 over hD4 and hD1 sites[1].


4-(4-acetylphenyl)-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]benzamide is an aromatic ketone.

4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE Basic Attributes

485.62

485.267853

0Y0CM1A77L

DTXSID6042602

Characteristics

61.9

4.47

white solid

1.132

688.7±55.0 °C at 760 mmHg

370.3±31.5 °C

1.582

DMSO: ~9 mg/mL at 60 °C, soluble

2-8°C

8.07E-19mmHg at 25°C

Safety Information

NONH for all modes of transport

3

22-24/25

Drug Information

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)

4''-acetyl-N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)(1,1''-biphenyl)-4-carboxamide

4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE Use and Manufacturing

A potent and selective dopamine D 3 receptor antagonist, with a K i value of 0.3 nM and > 100- fold selectivity over D 2 and D 4 sites.

Computed Properties

Molecular Weight:485.6
XLogP3:4.8
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:10
Exact Mass:485.26784199
Monoisotopic Mass:485.26784199
Topological Polar Surface Area:61.9
Heavy Atom Count:36
Complexity:677
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.